Viking Therapeutics, Inc. — All Filings
621 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0000950170-25-052162 | Apr 8, 2025 | May 20, 2025 |
| CORRESP | — | 0000950170-25-052253 | Apr 8, 2025 | — |
| 4/A | 4/A | 0000950170-25-052255 | Apr 8, 2025 | Mar 31, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-052198 | Apr 8, 2025 | — |
| 4 | 4 | 0000950170-25-049717 | Apr 2, 2025 | Mar 31, 2025 |
| UPLOAD | — | 0000000000-25-003431 | Mar 31, 2025 | — |
| 8-K | 8-K | 0000950170-25-036820 | Mar 11, 2025 | Mar 10, 2025 |
| 10-K | 10-K | 0000950170-25-027824 | Feb 26, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-014464 | Feb 5, 2025 | — |
| SCHEDULE 13G | — | 0002012383-25-000647 | Feb 4, 2025 | — |
| 4 | 4 | 0000950170-25-002483 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | 4 | 0000950170-25-002484 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | 4 | 0000950170-25-002485 | Jan 6, 2025 | Jan 3, 2025 |
| 4 | 4 | 0000950170-25-002486 | Jan 6, 2025 | Jan 3, 2025 |
| 4 | 4 | 0000950170-25-002487 | Jan 6, 2025 | Jan 3, 2025 |
| 144 | — | 0001950047-25-000163 | Jan 6, 2025 | — |
| 4 | 4 | 0000950170-25-002480 | Jan 6, 2025 | Jan 2, 2025 |
| 144 | — | 0001950047-25-000162 | Jan 6, 2025 | — |
| 4 | 4 | 0000950170-25-002481 | Jan 6, 2025 | Jan 2, 2025 |
| 144 | — | 0001950047-25-000164 | Jan 6, 2025 | — |
| 4 | 4 | 0000950170-25-002482 | Jan 6, 2025 | Jan 2, 2025 |
| SC 13G/A | — | 0000905148-24-003164 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000932471-24-001267 | Nov 12, 2024 | — |
| 4 | 4 | 0000950170-24-124296 | Nov 8, 2024 | — |
| 144 | — | 0001950047-24-008355 | Nov 8, 2024 | — |
| 8-K | 8-K | 0000950170-24-120267 | Nov 4, 2024 | — |
| SC 13G/A | — | 0000932471-24-000703 | Nov 4, 2024 | — |
| 144 | — | 0001950047-24-007913 | Oct 28, 2024 | — |
| 4 | 4 | 0000950170-24-117885 | Oct 28, 2024 | — |
| 4 | 4 | 0000950170-24-117514 | Oct 25, 2024 | — |
| 4 | 4 | 0000950170-24-117513 | Oct 25, 2024 | — |
| 144 | — | 0000103623-24-000081 | Oct 25, 2024 | — |
| 144 | — | 0000103623-24-000082 | Oct 25, 2024 | — |
| 8-K | 8-K | 0000950170-24-116642 | Oct 23, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-116708 | Oct 23, 2024 | Sep 30, 2024 |
| 144 | — | 0000103623-24-000077 | Sep 20, 2024 | — |
| 4 | 4 | 0000950170-24-108576 | Sep 20, 2024 | — |
| 4 | 4 | 0000950170-24-108577 | Sep 20, 2024 | — |
| 144 | — | 0000103623-24-000076 | Sep 20, 2024 | — |
| 4 | 4 | 0000950170-24-099982 | Aug 22, 2024 | Aug 21, 2024 |
| 4 | 4 | 0000950170-24-099980 | Aug 22, 2024 | Aug 21, 2024 |
| 144 | — | 0000103623-24-000074 | Aug 21, 2024 | — |
| 144 | — | 0000103623-24-000075 | Aug 21, 2024 | — |
| 4 | 4 | 0000950170-24-098803 | Aug 19, 2024 | — |
| 144 | — | 0000103623-24-000072 | Aug 19, 2024 | — |
| 144 | — | 0000103623-24-000073 | Aug 19, 2024 | — |
| 4 | 4 | 0000950170-24-098799 | Aug 19, 2024 | — |
| 144 | — | 0000103623-24-000070 | Aug 14, 2024 | — |
| 4 | 4 | 0000950170-24-097325 | Aug 14, 2024 | — |
| SC 13G/A | — | 0001086364-24-008371 | Aug 7, 2024 | — |